Drug Interactions with Fluconazole
Jeffrey D. Lazar, Keith D. Wilner · Clinical Infectious Diseases · 1990
Fluconazole, a water-soluble bis-triazole antifungal agent that effectively penetrates the cerebrospinal fluid, is a highly selective inhibitor of the fungal cytochrome P450 system. In single-dose studies, coadministration of cimetidine and fluconazole (100 mg) resulted in an insignificant decrease in the absorption of fluconazole. The coadministration of rifampin and fluconazole (200 mg) decreased both the half-life and the area under the plasma concentration-time curve (AUC) of fluconazole. In multiple-dose studies, fluconazole (50 mg) did not significantly alter the pharmacokinetics of the two steroid components of an oral contraceptive. Coadministration of tolbutamide with fluconazole (100 mg) increased both the maximal plasma concentration and the AUC of tolbutamide without changing levels of blood glucose. The coadministration of cyclosporin A with a low dose of fluconazole (100 mg) was not associated with significant changes in the minimal and the maximal plasma concentrations of cyclosporin A. While higher doses of fluconazole (200 mg) did not affect endogenous steroids, coadministration resulted in changes in the pharmacodynamics of warfarin and the pharmacokinetics of phenytoin and cyclosporin A.
Cited by 225 works. doi:10.1093/clinids/12.supplement_3.s327
Authors
References
- Ketoconazole Blocks Adrenal Steroid Synthesis
- Disposition of ketoconazole, an oral antifungal, in humans
- Pharmacokinetics and Tissue Penetration of Fluconazole in Humans
- High-Dose Ketoconazole Therapy and Adrenal and Testicular Function in Humans
- The influence of gastric acidity on the bio-availability of ketoconazole
- Clinical Pharmacokinetics of Ketoconazole
- Discovery of Fluconazole, a Novel Antifungal Agent
- Effect of pH on Disintegration and Dissolution of Ketoconazole Tablets
- Assessment of the drug metabolism capacity of the liver.
- Ketoconazole metamorphosis. An antimicrobial becomes an endocrine drug